羥基特他洛爾

羥基特他洛爾
臨床資料
其他名稱	4-Hydroxytertatolol
ATC碼	未分配;
識別資訊
	IUPAC命名法 82-Hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy4-thiochromanol; ;
CAS號	111897-93-9
PubChem CID	163871;
ChemSpider	143721;
UNII	RKM76FBC3F;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID70920605 ;
化學資訊
化學式	C16H25NO3S
摩爾質量	311.44 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES OC(CNC(C)(C)C)COc2cccc1c2SCCC1O;
	InChI InChI=1S/C16H25NO3S/c1-16(2,3)17-9-11(18)10-20-14-6-4-5-12-13(19)7-8-21-15(12)14/h4-6,11,13,17-19H,7-10H2,1-3H3; Key:RVGKVEPDZHPSBE-UHFFFAOYSA-N;

羥基特他洛爾（英語：Hydroxytertatolol）是一種含氮有機硫化合物，化學式C
16H
25NO
3S，為特他洛爾的衍生物，也能作為β受體阻滯劑^[1]^[2]。

參考文獻

^ Lave T, Efthymiopoulos C, Christmann D, Koffel JC, Jung L. Determination of 4-Hydroxytertatolol Stereoisomers in Rat and Human Urine by High-Performance Liquid Chromatography. Journal of Liquid Chromatography. 1995, 18 (14): 2801–2812. doi:10.1080/10826079508009325.
^ Bastian G, Urien S, Brée F, Jolliet P, Rocher I, Crambes O, Tillement JP. Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins. European Journal of Drug Metabolism and Pharmacokinetics. 1992, 17 (3): 233–236. PMID 1362702. S2CID 28632918. doi:10.1007/bf03190151.